Joel Gore to Warfarin
This is a "connection" page, showing publications Joel Gore has written about Warfarin.
Connection Strength
1.091
-
Ogunsua AA, Touray S, Lui JK, Ip T, Escobar JV, Gore J. Body mass index predicts major bleeding risks in patients on warfarin. J Thromb Thrombolysis. 2015 Nov; 40(4):494-8.
Score: 0.477
-
Shaw PB, Donovan JL, Tran MT, Lemon SC, Burgwinkle P, Gore J. Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic. J Thromb Thrombolysis. 2010 Aug; 30(2):220-5.
Score: 0.332
-
Chamoun N, Mac?as CG, Donovan JL, Klugman R, Gore J, Salameh P, Tran MT. Implications of an inpatient warfarin dosing nomogram on safety outcomes post-discharge. J Thromb Thrombolysis. 2017 May; 43(4):454-462.
Score: 0.132
-
Amad H, Yan AT, Yan RT, Huynh T, Gore JM, Montalescot G, DeYoung JP, Gallo R, Rose B, Steg PG, Goodman SG. The association between prior use of aspirin and/or warfarin and the in-hospital management and outcomes in patients presenting with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Can J Cardiol. 2012 Jan-Feb; 28(1):48-53.
Score: 0.091
-
Mohapatra R, Tran M, Gore JM, Spencer FA. A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era... Am Heart J. 2005 Jul; 150(1):19-26.
Score: 0.058